|
1
|
Wang L, Jahren N, Miller EL, Ketel CS,
Mallin DR and Simon JA: Comparative analysis of chromatin binding
by Sex Comb on Midleg (SCM) and other polycomb group repressors at
a Drosophila Hox gene. Mol Cell Biol. 30:2584–2593. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sathyamurthy A, Allen MD, Murzin AG and
Bycroft M: Crystal structure of the malignant brain tumor (MBT)
repeats in Sex Comb on Midleg-like 2 (SCML2). J Biol Chem.
278:46968–46973. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bornemann D, Miller E and Simon J: The
Drosophila Polycomb group gene Sex comb on midleg (Scm) encodes a
zinc finger protein with similarity to polyhomeotic protein.
Development. 122:1621–1630. 1996.PubMed/NCBI
|
|
4
|
Grimm C, de Ayala Alonso AG, Rybin V,
Steuerwald U, Ly-Hartig N, Fischle W, Müller J and Müller CW:
Structural and functional analyses of methyl-lysine binding by the
malignant brain tumour repeat protein Sex comb on midleg. EMBO Rep.
8:1031–1037. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peterson AJ, Mallin DR, Francis NJ, Ketel
CS, Stamm J, Voeller RK, Kingston RE and Simon JA: Requirement for
sex comb on midleg protein interactions in Drosophila polycomb
group repression. Genetics. 167:1225–1239. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guo J and Jin D: A genetic screen in
Drosophila implicates Sex comb on midleg (Scm) in tissue overgrowth
and mechanisms of Scm degradation by Wds. Mech Dev. 136:1–7. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
van de Vosse E, Walpole SM, Nicolaou A,
van der Bent P, Cahn A, Vaudin M, Ross MT, Durham J, Pavitt R,
Wilkinson J, et al: Characterization of SCML1, a new gene in Xp22,
with homology to developmental polycomb genes. Genomics. 49:96–102.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Berger J, Kurahashi H, Takihara Y, Shimada
K, Brock HW and Randazzo F: The human homolog of Sex comb on midleg
(SCMH1) maps to chromosome 1p34. Gene. 237:185–191. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Montini E, Buchner G, Spalluto C, Andolfi
G, Caruso A, den Dunnen JT, Trump D, Rocchi M, Ballabio A and
Franco B: Identification of SCML2, a second human gene homologous
to the Drosophila sex comb on midleg (Scm): A new gene cluster on
Xp22. Genomics. 58:65–72. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tomotsune D, Takihara Y, Berger J, Duhl D,
Joo S, Kyba M, Shirai M, Ohta H, Matsuda Y, Honda BM, et al: A
novel member of murine Polycomb-group proteins, Sex comb on midleg
homolog protein, is highly conserved and interacts with RAE28/mph1
in vitro. Differentiation. 65:229–239. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Usui H, Ichikawa T, Kobayashi K and
Kumanishi T: Cloning of a novel murine gene Sfmbt, Scm-related gene
containing four mbt domains, structurally belonging to the Polycomb
group of genes. Gene. 248:127–135. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen JH, Ni RZ, Xiao MB, Guo JG and Zhou
JW: Comparative proteomic analysis of differentially expressed
proteins in human pancreatic cancer tissue. Hepatobiliary Pancreat
Dis Int. 8:193–200. 2009.PubMed/NCBI
|
|
13
|
Xiao MB, Jiang F, Ni WK, Chen BY, Lu CH,
Li XY and Ni RZ: High expression of S100A11 in pancreatic
adenocarcinoma is an unfavorable prognostic marker. Med Oncol.
29:1886–1891. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xie L, Ni WK, Chen XD, Xiao MB, Chen BY,
He S, Lu CH, Li XY, Jiang F and Ni RZ: The expressions and clinical
significances of tissue and serum galectin-3 in pancreatic
carcinoma. J Cancer Res Clin Oncol. 138:1035–1043. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mia-Jan K, Munkhdelger J, Lee MR, Ji SY,
Kang TY, Choi E and Cho MY: Expression of CD133 in neuroendocrine
neoplasms of the digestive tract: A detailed immunohistochemical
analysis. Tohoku J Exp Med. 229:301–309. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Öberg K: Genetics and molecular pathology
of neuroendocrine gastrointestinal and pancreatic tumors
(gastroenteropancreatic neuroendocrine tumors). Curr Opin
Endocrinol Diabetes Obes. 16:72–78. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gastrointestinal Pathology Study Group of
Korean Society of Pathologists, ; Cho MY, Kim JM, Sohn JH, Kim MJ,
Kim KM, Kim WH, Kim H, Kook MC, Park DY, et al: Current trends of
the incidence and pathological diagnosis of gastroenteropancreatic
neuroendocrine tumors (GEP-NETs) in Korea 2000–2009: Multicenter
study. Cancer Res Treat. 44:157–165. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jernman J, Välimäki MJ, Louhimo J, Haglund
CJ and Arola J: The novel WHO 2010 classification for
gastrointestinal neuroendocrine tumours correlates well with the
metastatic potential of rectal neuroendocrine tumours.
Neuroendocrinology. 95:317–324. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kloppel G: Classification and pathology of
gastroenteropancreatic neuroendocrine neoplasms. Endocr Relat
Cancer. 18 Suppl 1:S1–S16. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Şahan EK, Erdoğan N, Ulusoy I, Samet E,
İğdem AA and Gönüllü D: P53, KI-67, CD117 expression in
gastrointestinal and pancreatic neuroendocrine tumours and
evaluation of their correlation with clinicopathological and
prognostic parameters. Turk J Gastroenterol. 26:104–111. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rindi G, Klöppel H, Alhman M, Caplin M,
Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M,
Komminoth P, et al: TNM staging of foregut (neuro)endocrine tumors:
A consensus proposal including a grading system. Virchows Arch.
449:395–401. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rindi G, Klöppel A, Couvelard P, Komminoth
P, Körner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A,
et al: TNM staging of midgut and hindgut (neuro) endocrine tumors:
A consensus proposal including a grading system. Virchows Arch.
451:757–762. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang YH, Yang QC, Lin Y, Xue L, Chen MH
and Chen J: Chromogranin A as a marker for diagnosis, treatment,
and survival in patients with gastroenteropancreatic neuroendocrine
neoplasm. Medicine (Baltimore). 93:e2472014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hasegawa K, Sin HS, Maezawa S, Broering
TJ, Kartashov AV, Alavattam KG, Ichijima Y, Zhang F, Bacon WC,
Greis KD, et al: SCML2 establishes the male germline epigenome
through regulation of histone H2A ubiquitination. Dev Cell.
32:574–588. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Luo M, Zhou J, Leu NA, Abreu CM, Wang J,
Anguera MC, de Rooij DG, Jasin M and Wang PJ: Polycomb protein
SCML2 associates with USP7 and counteracts histone H2A
ubiquitination in the XY chromatin during male meiosis. PLoS Genet.
11:e10049542015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lecona E, Narendra V and Reinberg D: USP7
cooperates with SCML2 to regulate the activity of PRC1. Mol Cell
Biol. 35:1157–1168. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bezsonova I: Solution NMR structure of the
DNA-binding domain from Scml2 (sex comb on midleg-like 2). J Biol
Chem. 289:15739–15749. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bonasio R, Lecona E, Narendra V, Voigt P,
Parisi F, Kluger Y and Reinberg D: Interactions with RNA direct the
Polycomb group protein SCML2 to chromatin where it represses target
genes. Elife. 3:e026372014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lecona E, Rojas LA, Bonasio R, Johnston A,
Fernández- Capetillo O and Reinberg D: Polycomb protein SCML2
regulates the cell cycle by binding and modulating CDK/CYCLIN/p21
complexes. PLoS Biol. 11:e10017372013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Old LJ: Cancer/testis (CT) antigens- a new
link between gametogenesis and cancer. Cancer Immun.
1:12001.PubMed/NCBI
|
|
31
|
Simpson AJ, Caballero OL, Jungbluth A,
Chen YT and Old LJ: Cancer/testis antigens, gametogenesis and
cancer. Nat Rev Cancer. 5:615–625. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zendman AJ, Ruiter DJ and Van Muijen GN:
Cancer/testis-associated genes: Identification, expression profile
and putative function. J Cell Physiol. 194:272–288. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Branco MR, King M, Perez-Garcia V, Bogutz
AB, Caley M, Fineberg E, Lefebvre L, Cook SJ, Dean W, Hemberger M
and Reik W: Maternal DNA methylation regulates early trophoblast
development. Dev Cell. 36:152–163. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Northcott PA, Nakahara Y, Wu X, Feuk L,
Ellison DW, Croul S, Mack S, Kongkham PN, Peacock J, Dubuc A, et
al: Multiple recurrent genetic events converge on control of
histone lysine methylation in medulloblastoma. Nat Genet.
41:465–472. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Grubach L, Juhl-Christensen C, Rethmeier
A, Olesen LH, Aggerholm A, Hokland P and Ostergaard M: Gene
expression profiling of Polycomb, Hox and Meis genes in patients
with acute myeloid leukaemia. Eur J Haematol. 81:112–122. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Qi L, Wang L, Huang J, Jiang M, Diao H,
Zhou H, Li X and Jiang Z: Activated amelogenin Y-linked (AMELY)
regulation and angiogenesis in human hepatocellular carcinoma by
biocomputation. Oncol Lett. 5:1075–1079. 2013.PubMed/NCBI
|
|
37
|
Wang Z, Li W, Chen T, Yang J, Luo L, Zhang
L, Sun B and Liang R: Retrospective analysis of the
clinicopathological characteristics of gastrointestinal
neuroendocrine neoplasms. Exp Ther Med. 10:1084–1088.
2015.PubMed/NCBI
|
|
38
|
Zhang X, Li M, Bao H, Zhang J, Wang Z and
Gong P: Clinical, pathological and prognostic characteristics of
gastroenteropancreatic neuroendocrine neoplasms in China: A
retrospective study. BMC Endocr Disord. 14:542014. View Article : Google Scholar : PubMed/NCBI
|
